Clinical trial
Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia
NCT00306319 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00306319 |
|---|---|
| Title | Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia |
| Official title | Pharmacokinetic Interaction Study of Rifampicin, Isoniazid and Moxifloxacin in Tuberculosis Patients in Bandung, Indonesia |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | moxifloxacin |
| Enrollment | 23 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Mar 23, 2006 |
| Last update posted | Nov 12, 2020 |
| Countries | Indonesia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: